Skip to content

Search for:

About us
LITOSeek™
- LITOSeek Platform
- Translational Medicine
News
Contact

Search for:

Philips3

By Sahar Hosseinian|2022-03-08T21:58:17+02:008 March 2022|

Share this content

Facebook X LinkedIn Email

About the Author: Sahar Hosseinian

Search for:

Recents posts

Novigenix AI Spin-Out to Accelerate AI-Powered Immune Intelligence 6 March 2026
Novigenix AI awarded EUR 1.8M in the groundbreaking BRECISE IHI Consortium to industrialize AI-powered liquid biopsy for prediction of immunotherapy response 31 March 2025
New study reveals novel multi-omics approach with unprecedented treatment response prediction in metastatic urothelial cancer 11 March 2025
Breakthrough study reveals blood transcriptomic alternations for early detection of colorectal cancer 27 November 2024
Understanding Tumor Immunology: How AI-powered blood RNA analysis could unlock immunotherapy prognoses 17 October 2024

Novigenix AI

Novigenix AI is a pioneering TechBio delivering liquid biopsy multi-omic solutions powered by the LITOSeek™ AI-RNA analytics platform to accelerate early cancer detection and development of effective therapies for better patient outcomes.

Contact us

Route de la Corniche 3
Phenyl Building
CH-1066 Epalinges
Switzerland
partnerships@novigenix.com

Follow us on LinkedIn

Recent posts

Novigenix AI Spin-Out to Accelerate AI-Powered Immune Intelligence
Novigenix AI awarded EUR 1.8M in the groundbreaking BRECISE IHI Consortium to industrialize AI-powered liquid biopsy for prediction of immunotherapy response

Newsletter

Name*
First name Last name
E-mail*
Your e-mail Confirm your e-mail

COPYRIGHT 2026 NOVIGENIX AI | ALL RIGHTS RESERVED | PRIVACY POLICY | POWERED BY AGENCE-ACP |

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Learn more Ok

Tracking Cookies